ERS TASK FORCE REPORT. Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations

Philip H. Quanjer, Sanja Stanojevic, Tim J. Cole, Xaver Baur, Graham L. Hall, Bruce H. Culver, Paul L. Enright, John L. Hankinson, Mary S.M. Ip, Jinping Zheng, Janet Stocks and the ERS Global Lung Function Initiative

Source: Guideline 2012
Number: 0
Disease area: Airway diseases

PDF journal article, handout or slides

Rating: 5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Philip H. Quanjer, Sanja Stanojevic, Tim J. Cole, Xaver Baur, Graham L. Hall, Bruce H. Culver, Paul L. Enright, John L. Hankinson, Mary S.M. Ip, Jinping Zheng, Janet Stocks and the ERS Global Lung Function Initiative. ERS TASK FORCE REPORT. Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations. Guideline 2012

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations
Source: Eur Respir J 2012; 40: 1324-1343
Year: 2012



LATE-BREAKING ABSTRACT: All-age multi-ethnic reference values for spirometry: The global lung function initiative (GLI)
Source: Annual Congress 2012 - Predicting the future: the impact of reference values on a range of respiratory paramaters
Year: 2012


"REDUCED MITOCHONDRIAL DENSITY IN THE VASTUS LATERALIS MUSCLE OF PATIENTS WITH COPD". H.R. GOSKER, M.K.C. HESSELINK, H. DUIMEL, K.A. WARD AND A.M.W.J. SCHOLS. EUR RESPIR J 2007; 30: 73 79.
Source: Eur Respir J 2007; 30: 817
Year: 2007


RELATIONSHIP BETWEEN RESPIRATORY SYMPTOMS AND MEDICAL TREATMENT IN EXACERBATIONS OF COPD. EUR RESPIR J 2005; 26: 406-413.
Source: Eur Respir J 2006; 27: 440
Year: 2006


LATE-BREAKING ABSTRACT: ASSOCIATION OF SEVERE EXACERBATION WITH FEV1 DECLINE AND LOSS OF AIRWAY REVERSIBILITY IN ASTHMA
Source: International Congress 2014 – Asthma: still a heterogeneous condition!
Year: 2014


Lung attacks in the ED: measurements to predict outcome. The AWARD study.
Source: International Congress 2017 – The acute patient: the clinical point-of-view
Year: 2017

The global Lund function initiative (GLI) reference values do not reflect lung function in the Nordic countries
Source: International Congress 2015 – Epidemiology of respiratory disease
Year: 2015

FOR PREPARATION: ERS abstract submission guidelines
Source:
Year: 2015

EOSINOPHIL COUNT AND FeNO AS PREDICTORS OF EXACERBACTIONS IN COPD
Source: International Congress 2018 – Clinical determinants and biomarkers of COPD
Year: 2018




BODE INDEX IN DIFFERENT PHENOTYPES OF COPD
Source: International Congress 2017 – What is new in COPD diagnosis and classification?
Year: 2017


IMPACT OF SMOKE-FREE WORKPLACE LEGISLATION ON EXPOSURES AND HEALTH: POSSIBILITIES FOR PREVENTION. M.S. JAAKKOLA AND J.J.K. JAAKKOLA. EUR RESPIR J 2006; 28: 397-408.
Source: Eur Respir J 2006 Oct 01;28(4):887-888
Year: 2006


Canadian prediction equation of spirometric lung function for caucasian adults 18-90 years: Results from the Canadian obstructive lung disease (COLD) study and the Canadian ECRHS study
Source: Annual Congress 2011 - Respiratory epidemiology: methods, definitions and phenotypes
Year: 2011

"TACROLIMUS FOR ANTISYNTHETASE SYNDROME WITH INTERSTITIAL LUNG DISEASE?" [REPLY LETTER]. L.P. NICOD. EUR RESPIR J 2008; 32: 245-246.
Source: Eur Respir J 2008; 32: 822
Year: 2008


Impact of severe exacerbations on lung function in dupilumab-treated patients: LIBERTY ASTHMA QUEST
Source: Virtual Congress 2021 – Pearls in immunology, outcome studies and clinical trials in asthma, alpha-1 antitrypsin deficiency and COPD
Year: 2021



"LUNG VOLUME MEASUREMENTS" [REPLY LETTER]. M. CAZZOLA, V. BRUSASCO AND F.J. MARTINEZ. EUR RESPIR J 2008; 32: 528.
Source: Eur Respir J 2008; 32: 822
Year: 2008


TORVAN VERSUS GAP: WHICH PERFORMS BETTER?
Source: Virtual Congress 2020 – Clinical aspects of idiopathic pulmonary fibrosis
Year: 2020


Classification of PFT data using global lung initiative (GLI) and national health and nutrition examination survey (NHANES-III) models when extrapolated beyond the NHANES-III limit of 80 years of age
Source: Annual Congress 2013 –Reference, reliability and risk: advances in lung function
Year: 2013


The recent multi-ethnic global lung initiative 2012 (GLI2012) reference values don’t reflect contemporary Mediterranean spirometry
Source: Annual Congress 2013 –Early diagnosis and effectiveness of disease management in primary care
Year: 2013

BUDESONIDE/FORMOTEROL MAINTENANCE AND RELIEVER THERAPY: AN EFFECTIVE ASTHMA TREATMENT OPTION? EUR RESPIR J 2005; 26: 819-828.
Source: Eur Respir J 2005; 26: 1191
Year: 2005


CAPTAIN: Effects of lung function at screening (FEV1 % predicted) as a continuous variable on treatment outcomes
Source: Virtual Congress 2021 – Asthma treatment: clinical and translational science
Year: 2021